Nearly 20 Percent of PrEP Users in the US Access HIV Prevention Medication Through Telemedicine

A recent study conducted by researchers at Emory University’s Rollins School of Public Health reveals that telemedicine plays a significant role in providing access to pre-exposure prophylaxis (PrEP) for HIV prevention. The findings, published in JAMA Network Open, estimate that nearly 20% of PrEP users in the United States—equating to over 110,000 individuals out of approximately 580,000 projected users nationwide in 2024—received their medication through telemedicine services.

The study highlights the growing reliance on telemedicine as a means to deliver critical healthcare services, particularly for HIV prevention. Researchers analyzed data to determine how many individuals accessed PrEP via virtual platforms rather than traditional in-person visits. The results underscore the potential of telemedicine to expand access to preventive care for populations who may face barriers such as geographic isolation or limited healthcare infrastructure. The findings provide insight into how technology is being utilized to address public health challenges and improve accessibility to essential medications.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: December 1, 2025

Related posts:

DrugPatentWatch.com Article Emphasizes Freedom to Operate Analyses to Avoid Biopharmaceutical Patent Infringement Lawsuits Blood Test Detects Breast Cancer Treatment Ineffectiveness Before Imaging Scans Molecular Allergy Chip Identifies Treatable Asthma Subtype in 70 Percent of Patients Study Finds 4,000 Daily Steps Linked to Lower Heart Disease Risk in Older Women

Author

GOAI